Literature DB >> 34006909

Integrated metabolomic analysis and cytokine profiling define clusters of immuno-metabolic correlation in new-onset psoriasis.

Elisabetta Tarentini1, Giulia Odorici1, Valeria Righi2, Alessia Paganelli1, Luca Giacomelli3, Valentina Mirisola3, Adele Mucci4, Luisa Benassi1, Elisabetta D'Aversa5, Claudia Lasagni1, Shaniko Kaleci1, Eva Reali6, Cristina Magnoni7.   

Abstract

The association between the metabolic profile and inflammatory cytokines in psoriasis is poorly understood. We analyzed the metabolic and cytokine/chemokine profiles in serum and skin from patients with new-onset psoriasis and healthy subjects (n = 7/group) by HR-MAS NMR and Bio-Plex immunoassay. Immuno-metabolic correlation matrix was analyzed in skin and serum to identify a potential immune-metabolic signature. Metabolomics analysis showed a significant increase in ascorbate and a decrease in scyllo-inositol, and a trend towards an increase in eight other metabolites in psoriatic skin. In serum, there was a significant increase of dimethylglycine and isoleucine. In parallel, psoriatic skin exhibited an increase of early inflammatory cytokines (IL-6, IL-8, TNF-α, IL-1β) and correlation analysis highlighted some major clusters of immune-metabolic correlations. A cluster comprising scyllo-inositol and lysine showed correlations with T-cell cytokines; a cluster comprising serine and taurine showed a negative correlation with early inflammatory cytokines (IL-6, G-CSF, CCL3). A strong positive correlation was enlightened between glutathione and inflammatory cytokines/angiogenesis promoters of psoriasis. The integration of metabolic and immune data indicated a molecular signature constituted by IL-6, IL1-ra, DMG, CCL4, Ile, Gly and IL-8, which could discriminate patients and healthy subjects and could represent a candidate tool in the diagnosis of new-onset psoriasis.

Entities:  

Year:  2021        PMID: 34006909     DOI: 10.1038/s41598-021-89925-7

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  48 in total

Review 1.  Psoriasis: a mixed autoimmune and autoinflammatory disease.

Authors:  Yun Liang; Mrinal K Sarkar; Lam C Tsoi; Johann E Gudjonsson
Journal:  Curr Opin Immunol       Date:  2017-07-22       Impact factor: 7.486

Review 2.  The "-OMICS" facet of melanoma: Heterogeneity of genomic, proteomic and metabolomic biomarkers.

Authors:  Douglas Donnelly; Phyu P Aung; George Jour
Journal:  Semin Cancer Biol       Date:  2019-07-08       Impact factor: 15.707

Review 3.  A brief look at the role of monocyte chemoattractant protein-1 (CCL2) in the pathophysiology of psoriasis.

Authors:  Shadi Behfar; Gholamhossein Hassanshahi; Alireza Nazari; Hossein Khorramdelazad
Journal:  Cytokine       Date:  2017-12-23       Impact factor: 3.861

Review 4.  Psoriasis.

Authors:  Wolf-Henning Boehncke; Michael P Schön
Journal:  Lancet       Date:  2015-05-27       Impact factor: 79.321

5.  Blood to skin recirculation of CD4+ memory T cells associates with cutaneous and systemic manifestations of psoriatic disease.

Authors:  Marco Diani; Marco Galasso; Chiara Cozzi; Francesco Sgambelluri; Andrea Altomare; Clara Cigni; Elena Frigerio; Lorenzo Drago; Stefano Volinia; Francesca Granucci; Gianfranco Altomare; Eva Reali
Journal:  Clin Immunol       Date:  2017-04-06       Impact factor: 3.969

Review 6.  Immunology of psoriasis.

Authors:  Michelle A Lowes; Mayte Suárez-Fariñas; James G Krueger
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

Review 7.  Psoriasis and comorbid diseases: Implications for management.

Authors:  Junko Takeshita; Sungat Grewal; Sinéad M Langan; Nehal N Mehta; Alexis Ogdie; Abby S Van Voorhees; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2017-03       Impact factor: 11.527

Review 8.  Psoriasis: Classical vs. Paradoxical. The Yin-Yang of TNF and Type I Interferon.

Authors:  Alessio Mylonas; Curdin Conrad
Journal:  Front Immunol       Date:  2018-11-28       Impact factor: 7.561

Review 9.  T Cell Hierarchy in the Pathogenesis of Psoriasis and Associated Cardiovascular Comorbidities.

Authors:  Fabio Casciano; Paolo D Pigatto; Paola Secchiero; Roberto Gambari; Eva Reali
Journal:  Front Immunol       Date:  2018-06-19       Impact factor: 7.561

Review 10.  Current Developments in the Immunology of Psoriasis.

Authors:  Franziska Grän; Andreas Kerstan; Edgar Serfling; Matthias Goebeler; Khalid Muhammad
Journal:  Yale J Biol Med       Date:  2020-03-27
View more
  3 in total

1.  Therapeutic Potential of Combining IL-6 and TNF Blockade in a Mouse Model of Allergic Asthma.

Authors:  Olga A Namakanova; Ekaterina A Gorshkova; Ruslan V Zvartsev; Sergei A Nedospasov; Marina S Drutskaya; Ekaterina O Gubernatorova
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

Review 2.  Current Knowledge in Skin Metabolomics: Updates from Literature Review.

Authors:  Alessia Paganelli; Valeria Righi; Elisabetta Tarentini; Cristina Magnoni
Journal:  Int J Mol Sci       Date:  2022-08-07       Impact factor: 6.208

3.  Toward Personalized Interventions for Psoriasis Vulgaris: Molecular Subtyping of Patients by Using a Metabolomics Approach.

Authors:  Dan Dai; Chunyan He; Shuo Wang; Mei Wang; Na Guo; Ping Song
Journal:  Front Mol Biosci       Date:  2022-07-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.